Cantel Medical (CMD) Getting Somewhat Positive Media Coverage, Study Shows
Headlines about Cantel Medical (NYSE:CMD) have been trending somewhat positive recently, Accern reports. The research group rates the sentiment of press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cantel Medical earned a news impact score of 0.06 on Accern’s scale. Accern also assigned news articles about the company an impact score of 44.6074622961421 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
Shares of Cantel Medical (NYSE CMD) opened at $109.21 on Thursday. The firm has a market capitalization of $4,654.24, a P/E ratio of 60.34 and a beta of 1.26. The company has a debt-to-equity ratio of 0.31, a current ratio of 2.44 and a quick ratio of 1.48. Cantel Medical has a 52-week low of $69.21 and a 52-week high of $116.79.
Cantel Medical (NYSE:CMD) last released its earnings results on Thursday, December 7th. The company reported $0.57 earnings per share for the quarter, topping analysts’ consensus estimates of $0.52 by $0.05. Cantel Medical had a return on equity of 17.42% and a net margin of 9.50%. equities analysts predict that Cantel Medical will post 2.35 EPS for the current fiscal year.
Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with MarketBeat.com's FREE daily email newsletter.